+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
FASENRA Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

FASENRA Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • November 2024
  • 191 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • November 2024
  • 216 Pages
  • Global
From
Bronchodilators Market Report by Indication, Drug Type, Route of Administration, and Region 2025-2033 - Product Thumbnail Image

Bronchodilators Market Report by Indication, Drug Type, Route of Administration, and Region 2025-2033

  • Report
  • September 2025
  • 147 Pages
  • Global
From
Cystic Fibrosis Therapeutics Market Report by Drug Class, Drug Molecule Type, Route of Administration, End-User, and Region 2025-2033 - Product Thumbnail Image

Cystic Fibrosis Therapeutics Market Report by Drug Class, Drug Molecule Type, Route of Administration, End-User, and Region 2025-2033

  • Report
  • August 2025
  • 118 Pages
  • Global
From
Asthma Therapeutics Market Size, Share, Trends and Forecast by Drug Class, Product Type, Treatment Type, Route of Administration, and Region, 2025-2033 - Product Thumbnail Image

Asthma Therapeutics Market Size, Share, Trends and Forecast by Drug Class, Product Type, Treatment Type, Route of Administration, and Region, 2025-2033

  • Report
  • August 2025
  • 136 Pages
  • Global
From
Alpha 1 Antitrypsin Deficiency Treatment Market Report by Treatment Type, Route of Administration, End User, and Region 2025-2033 - Product Thumbnail Image

Alpha 1 Antitrypsin Deficiency Treatment Market Report by Treatment Type, Route of Administration, End User, and Region 2025-2033

  • Report
  • August 2025
  • 123 Pages
  • Global
From
Anti-Tuberculosis Therapeutics Market 2025-2033 - Product Thumbnail Image

Anti-Tuberculosis Therapeutics Market 2025-2033

  • Report
  • March 2025
  • 146 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033

  • Report
  • February 2025
  • 150 Pages
  • Global
From
Sleep Apnea - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 250 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Emphysema - Pipeline Insight, 2025 - Product Thumbnail Image

Emphysema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Pleural Effusion - Pipeline Insight, 2025 - Product Thumbnail Image

Pleural Effusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2025 - Product Thumbnail Image

Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Sinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more